Non-steroidal anti-inflammatory analgesics: A review of current practice

Journal of Veterinary Emergency and Critical Care

Volumn 12, Issue 2, 2002, Pages 89-97

  Mathews, Karol A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cats and dogs; Cox 1; Cox 2; Non steroidal anti inflammatory analgesics; Non steroidal anti inflammatory drugs; Pain management

Indexed keywords

EID: 0041646202     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1046/j.1435-6935.2002.00007.x     Document Type: Review

References (61)

1. Vane JR, Botting RM. New insights into mode of action of anti-inflammatory drugs. Inflamm Res 1995; 44: 1–10.pmid/7664022
2. Malmberg NB, Yaksh L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136–146.pmid/1403779
3. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12: 1063–1073.pmid/9737710
4. Schmassmann A, Peskar BM, Stettler C, et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol 1998; 123: 795–804.pmid/9535006
5. Reuter BK, Asfaha S, Buret A, et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 1996; 98: 2076–2085.pmid/8903327
6. Harris RC. Cyclooxygenase-2 in the kidney. Am Soc Nephrol 2000; 11: 2387–2394.
7. Imig JD. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 2000; 279: F965–F981.pmid/11097615
8. Fosslieu E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 2000; 30: 3–21.pmid/10678579
9. Lipsky PE. Specific COX-2 inhibitors in arthritis, oncology and beyond: Where is the science headed? Rheumatol 1999; 26(suppl 56): 25–30.
10. Smalley WE, Dubois RN. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol 1997; 39: 1–20.pmid/9160111
11. McKormack K. Non-steroidal anti-inflammatory drugs and spinal processing. Pain 1994; 59: 9–43.pmid/7854808
12. McKormack K. The spinal actions of non-steroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs 1994; 47(Suppl 15): 28–45.
13. Yaksh TL, Dirig DM, Malmberg AB. Mechanism of action of nonsteroidal anti-inflammatory drugs. Cancer Invest 1998; 16: 509–527.pmid/9774958
14. Lascelles BDX, Capner CA, Waterman-Pearson A. Current British veterinary attitudes to perioperative analgesia for cats and small mammals. Vet Rec 1999; 145: 601–604.
15. Grisnaux E, Pibarot P, Dupuis J. Comparison of ketoprofen and carprofen administered prior to orthopedic surgery for control of postoperative pain in dogs. J Am Vet Med Assoc 1999; 215: 1105–1110.pmid/10530322
16. Mathews KA. Special report on non-steroidal antiinflammatory analgesics for pain management in cats and dogs. Can Vet J 1996; 37: 539–545.pmid/8877039
17. Mathews KA, Paley DM, Foster RF, et al. A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs. Can Vet J 1996; 37: 557–567.pmid/8877043
18. Mathews KA, Pettifer G, Foster R, et al. A comparison of the safety and efficacy of meloxicam to ketoprofen and butorphanol for control of post-operative pain associated with soft tissue surgery in dogs. In: Proceedings of the Symposium on Recent Advances in Non-Steroidal Anti-Inflammatory Therapy in Small Animals, Paris, 1999, p. 67.
19. Mathews KA, Doherty T, Dyson DH, et al. Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia. Can Vet J 1990; 31: 766–771.
20. Cayen MN, Kraml M, Ferdinandi ES. The metabolic disposition of etodolac in rats, dogs and man. Drug Metab Rev 1981; 2: 363–377.
21. 2 concentrations after single dose administration of ketorolac tromethamine (Toradol) in dogs. Can J Vet Res 1998; 62: 237–240.pmid/9684056
22. Schleimer RP, Benjamin E. The effects of prostaglandin synthesis inhibition of the immune response. J Immunopharmacol 1981; 3: 205–219.pmid/6121831
23. Pibarot P, Dupuis J, Grisneaux E, et al. Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in the treatment of postoperative pain in dogs. J Am Vet Med Assoc 1997; 211: 438–444.pmid/9267504
24. Schmidt H. Efficacy and safety of meloxicam in the control of peri-operative pain in the dog. In: Proceedings of the Symposium on Recent Advances in Non-Steroidal Anti-Inflammatory Therapy in Small Animals, Paris, 1999, pp. 71–74.
25. Lascelles BDX, Butterworth SJ, Waterman AE. Postoperative analgesic and sedative effects of carprofen and pethidine in dogs. Vet Rec 1994; 134: 187–191.pmid/8171793
26. Lascelles BDX, Cripps P, Mirchandani S, et al. Carprofen as an analgesic for postoperative pain in cats: Dose titration and assessment of efficacy in comparison to pethidine hydrochloride. J Small Anim Pract 1995; 36: 535–541.pmid/8926722
27. Lascelles BDX, Cripps PJ, Jones A, et al. Efficacy and kinetics of carprofen, administered preoperatively or postoperatively, on the prevention of pain in dogs undergoing ovariohysterectomy. Vet Surg 1998; 27: 568–582.pmid/9845221
28. Nolan A, Reid J. Comparison of the postoperative analgesic and sedative effects of carprofen and papaveretum in the dog. Vet Rec 1993; 133: 240–242, 1993.pmid/8236640
29. Reid J, Nolan AM. A comparison of the postoperative analgesic and sedative effects of flunixin and papaveretum in the dog. J Small Anim Pract 1991; 32: 603–608.
30. Slingsby LS, Waterman-Pearson AE. Comparison of pethidine, buprenorphine and ketoprofen for postoperative analgesia after ovariohysterectomy in the cat. Vet Rec 1998; 143: 185–189.pmid/9762758
31. Taylor PM. Newer analgesics. Nonsteroidal anti-inflammatory drugs, opioids and combinations. Vet Clin North Am Small Anim Pract 1999; 29: 719–735.
32. Prescott JF, Miller CW, Mathews KA. Cross-Canada disease report: Update on canine streptococcal toxic shock syndrome and necrotizing fasciitis. Can Vet J 1997; 38: 241–242.pmid/9105725
33. Holtsinger RH, Parker RB, Beale BS. The therapeutic efficacy of carprofen (Rimadyl-V) in 209 clinical cases of canine degenerative joint disease. J Vet Comp Orthop Trauma 1992; 5: 140–144.
34. Doig PA, Purbrick KA, Hare JE. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis. Can Vet J 2000; 41: 296–300.pmid/10769766
35. Budsberg SC, Johnston SA, Schwarz PD. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. J Am Vet Med Assoc 1999; 214: 206–210.pmid/9926009
36. Allyn M, Johnston S, Leib M, et al. The gastroduodenal effects of buffered aspirin, carprofen and etodolac in the dog. In: Proceedings of the 16th Annual American College of Veterinary Internal Medicine Veterinary Medical Forum, San Diego, 1998, p. 731.
37. Reimer ME, Johnston SA, Leib MS, et al. The gastroduodenal effects of buffered aspirin, carprofen and etodolac in healthy dogs. J Vet Intern Med 1999; 13: 472–477.pmid/10499732
38. Forsyth SF, Guilford WG, Lowoko CRO. Endoscopic evaluation of the gastroduodenal mucosa following non-steroidal anti-inflammatory drug administration in the dog. NZ Vet J 1996; 44: 179–171.
39. Forsyth SF, Guilford WG, Haslett SJ, et al. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs. J Small Anim Pract 1998; 39: 421–424.pmid/9791828
40. Benton HP, Vasseur PB, Broderick-Villa GA, et al. Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis and prostaglandin release by cultured osteoarthritic canine chondrocytes. Am J Vet Res 1997; 58: 286–292.pmid/9055976
41. Budsberg SC, Schneider TA, Reynolds L. Plasma and synovial concentrations of carprofen in dogs with chronic unilateral stifle osteoarthritis. In: Proceedings of the Veterinary Orthopedic Society 26th Annual Conference, Sun Valley, ID, 1999, p. 44.
42. Rainsford KD, Skerry TM, Chindemi P, et al. Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs. Vet Res Commun 1999; 23: 101–113.pmid/10359154
43. Abeles V, Harrus S, Angles JM, et al. Hypertrophic osteodystrophy in six Weimaraner puppies associated with systemic signs. Vet Rec 1999; 14: 130–134.
44. McQuay H, Moore A. Topically applied non-steroidal anti-inflammatory drugs. In: McQuay H, Moore A (editors). An evidence-based resource for pain relief. New York: Oxford University Press Inc, 1998, pp. 102–107.
45. Evans JMM, McMahon A, McGilchrist M, et al. Topical non-steroidal antiinflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: A record linkage case-control study. Br Med J 1995; 311: 22–26.
46. Poulsen Nautrup B, Justus C. Effects of some veterinary NSAIDs on ex vivo thromboxane production and in vivo urine output in the dog. In: Proceedings of the Symposium on Recent Advances in Non-Steroidal Anti-Inflammatory Therapy in Small Animals, Paris, 1999, pp. 25–28.
47. Cross AR, Budsberg SC, Keefe TJ. Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs. Am J Vet Res 1997; 58: 626–631.pmid/9185970
48. Edgar PC. Seven cases of panosteitis in the German Shepherd dog. Vet Times 1998; 11: 22–23.
49. Lascelles BDX, Waterman A. Analgesia in cats. In Practice 1997; 19: 203–213.
50. Kay-Mugford P, Benn SJ, LaMarre J. In vitro evaluation of the effects of non-steroidal anti-inflammatory drugs on cyclooxygenase-1 and -2 in the dog.
51. Ricketts AP, Lundy KM, Seibel SB. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am J Vet Res 1998; 59: 1441–1446.pmid/9829404
52. McKellar QA, Pearson T, Bogan JA, et al. Pharmacokinetics, tolerance and serum thromboxane inhibition of carprofen in the dog. J Small Anim Pract 1990; 31: 443–448.
53. MacPhail CM, Lappin MR, Meyer DJ, et al. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs. J Am Vet Med Assoc 1998; 12: 1895–1901.
54. McKellar QA, Lees P, Gettinby G. Pharmacodynamics of tolfenamic acid in dogs. Evaluation of dose response relationships. Eur J Pharmacol 1994; 253: 191–200.pmid/8200415
55. McNeil PE. Acute tubulo-interstitial nephritis in a dog after halothane anaesthesia and administration of flunixin meglumine and trimethoprim-sulphadiazine. Vet Rec 1992; 131: 148–151.pmid/1413422
56. Vonderhaar MA, Salisbury SK. Gastroduodenal ulceration associated with flunixin meglumine administration in three dogs. J Am Vet Med Assoc 1993; 201: 92–95.
57. Silverstein FE, Faich G, Goldstein JL. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomised controlled trial. J Am Med Assoc 2000; 284: 1247–1255.
58. Wood AJJ. The Coxibs, Selective Inhibitors of Cyclooxygenase-2. New Engl J Med 2001; 345(6):443–442.pmid/11496856
59. 4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993; 34: 742–747.pmid/8390958
60. Rainsford KD. Mechanisms of NSAID-induced ulcerogenesis. Structural properties of drugs, focus on the microvascular factors, and novel approaches for gastro-intestinal protection. Acta Physiol Hung 1992; 80: 23–38.pmid/1345192
61. Kirchner T, Argentieri DC, Barbone AG. Evaluation of the anti-inflammatory activity of a dual cyclooxygenase-2 selective/5 lipoxygenase inhibitor RWJ 63556, in a canine model of inflammation. J Pharmacol Exp Ther 1997; 282: 1094–1101.pmid/9262379